Detailed Information on Publication Record
2019
Negative prognostic significance of primary cilia, CD8+tumor infiltrating lymphocytes and PD1+cells expression in clear cell renal cancer
ROZSYPALOVA, Aneta, Blanka ROSOVA, Alzbeta FILIPOVA, Dimitar Hadzi NIKOLOV, Renata CHLOUPKOVÁ et. al.Basic information
Original name
Negative prognostic significance of primary cilia, CD8+tumor infiltrating lymphocytes and PD1+cells expression in clear cell renal cancer
Authors
ROZSYPALOVA, Aneta (203 Czech Republic), Blanka ROSOVA (203 Czech Republic), Alzbeta FILIPOVA (203 Czech Republic), Dimitar Hadzi NIKOLOV (203 Czech Republic), Renata CHLOUPKOVÁ (203 Czech Republic, belonging to the institution), Igor RICHTER (203 Czech Republic), Jan PROKS (203 Czech Republic), Roman ZACHOVAL (203 Czech Republic), Radoslav MATEJ (203 Czech Republic), Bohuslav MELICHAR (203 Czech Republic), Tomas BUCHLER (203 Czech Republic) and Josef DVORAK (203 Czech Republic, guarantor)
Edition
Journal of BUON, Athens, ZERBINIS MEDICAL PUBL, 2019, 1107-0625
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
Greece
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.695
RIV identification code
RIV/00216224:14110/19:00108594
Organization unit
Faculty of Medicine
UT WoS
000481595900047
Keywords in English
clear cell renal cancer; primary cilia; CD8+tumor infiltrating lymphocytes; programmed cell death protein 1
Tags
International impact, Reviewed
Změněno: 14/4/2020 14:28, Mgr. Tereza Miškechová
Abstract
V originále
Purpose: The aim of this study was to investigate the potential association and combined prognostic significance of the frequency of primary cilia (PC), programmed cell death protein-1 receptor (PD1) and CD8+ tumor infiltrating lymphocytes (TIL) in patients with clear cell renal cancer (ccRCC). Methods: The frequency of PC, PD1 expression and the frequency of intratumoral CD8+ TIL were evaluated in 104 ccRCC patients. Results: The median frequency of PC was 0.003. The expression of PD1+ cells were <5% in 52 patients, 5-25% in 34 patients and 26-50% in 13 patients and >50% in 5 patients. Intratumoral CD8+ TIL were evaluable in all patients: negative in 1 patient, <25% in 63, 26-50% in 29 and >50% in 11 patients. Overall survival (OS) according to the frequency of PC was significantly shorter in patients with higher frequency (>= 0.002) than in patients with lower frequency (<0.002) (p<0.001). Median OS was significantly shorter in patients with higher (25%) CD8+ TIL and higher (>25%) PD1+ expression than in patients with lower (<25%) expression (4.6 vs. 97. years, p=0.006 and 2.9 vs. 8.9 years, p=0.006, respectively). Conclusions: The present study provides the first data on the potential association and combined prognostic significance of frequency of PC, PD1+ cells and CD8+ TIL in patients with clear cell renal cancer.
Links
NV15-34678A, research and development project |
|